Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Short-Course Radiation in Elderly Glioblastoma
NCT00482677Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Nov 2007
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of temozolomide in glioblastoma multiforme (GBM), sponsored by Canadian Cancer Trials Group. Started Nov 2007; status: completed.
02
Drugs
temozolomide
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00482677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482677.